Dayang Erna-Zulaikha

Dr. Dayang Erna-Zulaikha

Paraclinical Sciences Department, Universiti Malaysia Sarawak, Kuching, Sarawak, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
DEDayang Erna-Zulaikha
Dayang Erna-Zulaikha
JPJosée Plantinga
Josée Plantinga
BEBram ter Ellen
Bram ter Ellen
MMMatijs van Meurs
Matijs van Meurs
GMGrietje Molema
Grietje Molema
JMJill Moser
Jill Moser
Sepsis is a life-threatening condition caused by a dysregulated host response to infection. Endothelial cells (EC) are actively involved in sepsis-associated (micro)vascular disturbances and subsequent organ dysfunction. Lipopolysaccharide (LPS), a Gram-negative bacterial product, can activate EC leading to the expression of pro-inflammatory molecules. This process is molecularly regulated by specific receptors and distinct, yet poorly understood intracellular signaling pathways. LPS-induced expression of endothelial adhesion molecules E-selectin and VCAM-1 in mice was previously shown to be organ- and microvascular-specific. Here we report that also within renal microvascular beds the endothelium expresses different extents of E-selectin and VCAM-1. This heterogeneity was recapitulated in vitro in LPS-activated human umbilical vein EC (HUVEC). Within 2 h after LPS exposure, four distinct HUVEC subpopulations were visible by flow cytometric analysis detecting E-selectin and VCAM-1 protein. These encompassed E-selectin−/VCAM-1− (–/–), E-selectin+/VCAM-1− (E-sel+), E-selectin+/VCAM-1+ (+/+), and E-selectin−/VCAM-1+ (VCAM-1+) subpopulations. The formation of subpopulations was a common response of endothelial cells to LPS challenge. Using fluorescence-activated cell sorting (FACS) we demonstrated that the +/+ subpopulation also expressed the highest levels of inflammatory cytokines and chemokines. The differences in responsiveness of EC subpopulations could not be explained by differential expression of LPS receptors TLR4 and RIG-I. Functional studies, however, demonstrated that the formation of the E-sel+ subpopulation was mainly TLR4-mediated, while the formation of the +/+ subpopulation was mediated by both TLR4 and RIG-I. Pharmacological blockade of NF-κB and p38 MAPK furthermore revealed a prominent role of their signaling cascades in E-sel+ and +/+ subpopulation formation. In contrast, the VCAM-1+ subpopulation was not controlled by any of these signaling pathways. Noteworthy is the existence of a “quiescent” subpopulation that was devoid of the two adhesion molecules and did not express cytokines or chemokines despite LPS exposure. Summarizing, our findings suggest that LPS activates different signaling mechanisms in EC that drive heterogeneous expression of EC inflammatory molecules. Further characterization of the signaling pathways involved will enhance our understanding of endothelial heterogeneous responses to sepsis related stimuli and enable the future design of effective therapeutic strategies to interfere in these processes to counteract sepsis-associated organ dysfunction.

1 January 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DEDayang Erna-Zulaikha
Dayang Erna-Zulaikha
MLMatthijs Luxen
Matthijs Luxen
TKTimara Kuiper
Timara Kuiper
RYRui Yan
Rui Yan
SRSavithri Rangarajan
Savithri Rangarajan
GMGrietje Molema
Grietje Molema
Sepsis is a life-threatening condition often leading to multiple organ failure for which currently no pharmacological treatment is available. Endothelial cells (EC) are among the first cells to respond to pathogens and inflammatory mediators in sepsis and might be a sentinel target to prevent the occurrence of multiple organ failure. Lipopolysaccharide (LPS) is a Gram-negative bacterial component that induces endothelial expression of inflammatory adhesion molecules, cytokines, and chemokines. This expression is regulated by a network of kinases, the result of which in vivo enables leukocytes to transmigrate from the blood into the underlying tissue, causing organ damage. We hypothesised that besides the known kinase pathways, other kinases are involved in the regulation of EC in response to LPS, and that these can be pharmacologically targeted to inhibit cell activation. Using kinome profiling, we identified 58 tyrosine kinases (TKs) that were active in human umbilical vein endothelial cells (HUVEC) at various timepoints after stimulation with LPS. These included AXL tyrosine kinase (Axl), focal adhesion kinase 1 (FAK1), and anaplastic lymphoma kinase (ALK). Using siRNA-based gene knock down, we confirmed that these three TKs mediate LPS-induced endothelial inflammatory activation. Pharmacological inhibition with FAK1 inhibitor FAK14 attenuated LPS-induced endothelial inflammatory activation and leukocyte adhesion partly via blockade of NF-κB activity. Administration of FAK14 after EC exposure to LPS also resulted in inhibition of inflammatory molecule expression. In contrast, inhibition of ALK with FDA-approved inhibitor Ceritinib attenuated LPS-induced endothelial inflammatory activation via a pathway that was independent of NF-κB signalling while it did not affect leukocyte adhesion. Furthermore, Ceritinib administration after start of EC exposure to LPS did not inhibit inflammatory activation. Combined FAK1 and ALK inhibition attenuated LPS-induced endothelial activation in an additive manner, without affecting leukocyte adhesion. Summarising, our findings suggest the involvement of FAK1 and ALK in mediating LPS-induced inflammatory activation of EC. Since pharmacological inhibition of FAK1 attenuated endothelial inflammatory activation after the cells were exposed to LPS, FAK1 represents a promising target for follow up studies.

26 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
ZWZhendong Wang
Zhendong Wang
DEDayang Erna-Zulaikha
Dayang Erna-Zulaikha
PZPeter J. Zwiers
Peter J. Zwiers
MGMartha L. Hernandez Garcia
Martha L. Hernandez Garcia
MLMatthijs Luxen
Matthijs Luxen
GMGrietje Molema
Grietje Molema
Background: Sepsis is an uncontrolled systemic inflammatory response to an infection that can result in acute failure of the function of the lung called acute respiratory distress syndrome. Leukocyte recruitment is an important hallmark of acute lung failure in patients with sepsis. Endothelial cells (EC) participate in this process by facilitating tethering, rolling, adhesion, and transmigration of leukocytes via adhesion molecules on their cell surface. In in vivo studies, endothelial nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 and mitogen-activated protein kinase (MAPK) c-Jun intracellular signal transduction pathways were reported to regulate the expression of adhesion molecules. Methods: Mice underwent cecal ligation and puncture (CLP) to induce polymicrobial sepsis and were sacrificed at different time points up to 72 h after sepsis onset. Immunohistochemistry and reverse transcription–quantitative polymerase chain reaction (RT-qPCR) analyses were used to determine the kinetics of nuclear localization of p65 and c-Jun in EC, expression and location of adhesion molecules E-selectin and vascular cell adhesion molecule 1 (VCAM-1). Furthermore, the extent and location of leukocyte recruitment were assessed based on Ly6G staining of neutrophils, cluster determinant (CD) 3 staining of T lymphocytes, and CD68 staining of macrophages. Results: In all pulmonary microvascular beds, we identified p65 and c-Jun nuclear accumulation in a subset of endothelial cells within the first 24 h after CLP-sepsis initiation. E-selectin protein was expressed in a subset of microvessels at 4 and 7 h after sepsis initiation, while VCAM-1 was expressed in a scattered pattern in alveolar tissue and microvessels, without discernible changes during sepsis development. CLP-induced sepsis predominantly promoted the accumulation of neutrophils and T lymphocytes 4 and 7 h after disease onset. Neutrophil accumulation occurred in all pulmonary microvascular beds, while T lymphocytes were present in alveolar tissue and postcapillary venules. Taken together, nuclear localization of p65 and c-Jun in EC and neutrophil recruitment could be associated with induced E-selectin expression in the pulmonary microvessels in CLP-septic mice at the early stage of the disease. In alveolar capillaries, on the other hand, activation of these molecular pathways and leukocyte accumulation occurred in the absence of E-selectin or VCAM-1. Conclusions: Endothelial activation and leukocyte recruitment in sepsis-induced lung injury are regulated by multiple, heterogeneously controlled mechanisms, which vary depending on the type of microvascular bed involved.

2 July 2024 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
ZWZhendong Wang
Zhendong Wang
DEDayang Erna-Zulaikha
Dayang Erna-Zulaikha
PZPeter J. Zwiers
Peter J. Zwiers
MGMartha L Hernandez Garcia
Martha L Hernandez Garcia
MLMatthijs Luxen
Matthijs Luxen
GMGrietje Molema
Grietje Molema
Sepsis is a dysregulated systemic inflammatory response to an infection, which can lead to multiple organ dysfunction syndrome that includes the kidney. Leukocyte recruitment is an important process of the host immune defense in response to sepsis. Endothelial cells (EC) actively regulate leukocyte recruitment by expressing adhesion molecules following the activation of dedicated intracellular signal transduction pathways. Previous studies reported that the expression of adhesion molecules was associated with the activation of endothelial NF-κB p65 and MAPK c-Jun pathways in vitro in response to conditions that mimic processes that occur in inflammation. This study aimed to investigate the spatiotemporal patterns of leukocyte recruitment, expression of adhesion molecules, and endothelial nuclear p65 and c-Jun localization in renal microvascular beds of septic mice. Here, we used a cecal ligation and puncture (CLP) sepsis mouse model and RT-qPCR and immunohistochemical staining. We showed that neutrophils, macrophages, and T lymphocytes were all present in the kidney, yet only neutrophils accumulated in a spatiotemporally discernible pattern, mainly in glomeruli at 4 hours after CLP-sepsis initiation. E-selectin, not VCAM-1, was expressed in glomeruli at the same time point. In a subset of mice at 72 hours after CLP-sepsis started, VCAM-1 expression was prominent in glomerular EC, which was not related to changes in mmu-microRNA(miR)-126a-3p levels, a short noncoding microRNA previously shown to inhibit the translation of VCAM-1 mRNA into protein. Nuclear localization of p65 and c-Jun occurred in EC of all microvascular segments at 4 and 7 hours after CLP-sepsis initiation. In summary, sepsis-induced recruitment of neutrophils, E-selectin expression, and NF-κB p65 and MAPK c-Jun pathway activation coincided in glomeruli at the early stage of the disease. In the other microvascular beds, sepsis led to NF-κB p65 and MAPK c-Jun pathway activation with limited expression of E-selectin and no association with VCAM-1 expression or leukocyte recruitment.

1 January 2026 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
SJSiti Marliana Jasni
Siti Marliana Jasni
YSYiizamy Suffian
Yiizamy Suffian
NZNor Hisam Zamakshshari
Nor Hisam Zamakshshari
DEDayang Erna-Zulaikha
Dayang Erna-Zulaikha
Atherosclerosis is a chronic inflammatory disorder that involves endothelial dysfunction and accumulation of inflammatory cells in the vessel intima. Approximately 32% of global mortality is attributed to cardiovascular diseases, with atherosclerosis playing a major role. Endothelial dysfunction is a key hallmark of atherosclerosis, with key mediator tumor necrosis factor‐α (TNF‐α) driving endothelial–monocyte interactions that further lead to adverse cardiovascular events. Hydroxychavicol, a phenolic compound enriched in Piper betle (PB), methanolic and chloroform extracts, has demonstrated anti‐inflammatory activity, yet its effects on endothelial activation remain insufficiently characterized. Therefore, this study aimed to investigate the endothelial‐protective effects of hydroxychavicol‐rich PB methanol (PB‐M) and chloroform (PB‐C) extracts by evaluating their impact on the expression of adhesion molecules and proinflammatory cytokines in TNF‐α‐induced human umbilical vein endothelial cells (HUVECs). HPLC was performed to confirm the presence and determine the amount of hydroxychavicol in both PB‐M and PB‐C. The cytotoxicity effects of both extracts were first assessed by MTT assay. HUVECs were pretreated with NF‐κB inhibitor BAY11‐7082, PB‐M, or PB‐C before being exposed to TNF‐α for 4 h. Adhesion molecules and cytokines expression were measured by Western blot and ELISA, respectively. Both PB‐M and PB‐C were shown to contain hydroxychavicol, yet PB‐C has about 3.8 times higher levels. MTT assays yielded IC 50 values of 128.9 µg/mL for PB‐M and 18.59 µg/mL for PB‐C, while HUVEC morphology remained normal at 100 µg/mL PB‐M and 20 µg/mL PB‐C. Both extracts displayed dose‐dependent suppressing effects on TNF‐α‐induced E‐selectin, VCAM‐1, and ICAM‐1 expression. PB‐M resulted in a pronounced inhibition of IL‐6, IL‐8, and MCP‐1, while PB‐C displayed cytokine‐selective suppressive effects. In conclusion, both PB‐M and PB‐C attenuated TNF‐α‐induced endothelial inflammation, with PB‐C acting at lower effective doses but PB‐M providing broader anti‐inflammatory suppression, suggesting that their different phytochemical compositions and possible synergistic interactions beyond hydroxychavicol may contribute to their distinct bioactivities, warranting further investigations.

4 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LJLuqman Jaya
Luqman Jaya
NZNor Hisam Zamakshari
Nor Hisam Zamakshari
NZNur Fazlin Zafirah Zaine
Nur Fazlin Zafirah Zaine
MAMajed Ahmed Al-Mansoub
Majed Ahmed Al-Mansoub
MNMohammad Zulkarnaen Ahmad Narihan
Mohammad Zulkarnaen Ahmad Narihan
DEDayang Erna-Zulaikha
Dayang Erna-Zulaikha
Ethnopharmacological relevanceThe genus Garcinia has been traditionally used in tropical regions of Southeast Asia, and Africa for the treatment of fever, inflammation, gastrointestinal disorders, and wound healing. Various parts of the plant, including the bark, leaves, fruits, and stem bark, have been widely employed in traditional medicine. Garcinia species are rich in prenylated xanthones and benzophenones, which exhibit diverse pharmacological activities, particularly anti-inflammatory effects. However, despite their extensive ethnomedicinal use and increasing phytochemical investigations, pharmacological studies have primarily focused on a limited number of species, such as Garcinia mangostana and Garcinia cowa, whereas the anti-inflammatory potential of lesser-studied species, including Garcinia dryobalanoides and its major xanthone constituent, rubraxanthone, in ameliorating endothelial dysfunction remains relatively underexplored.Aim of the studyThis study evaluated the anti-inflammatory effects of rubraxanthone on LPS-induced endothelial activation.Materials and methods Rubraxanthone was isolated and characterised using NMR, HPLC, and LC–MS. Cell viability in human umbilical vein endothelial cells (HUVECs) was assessed via CCK-8 assay. HUVECs were pre-treated with rubraxanthone (2.5–10 µM) or BAY 11-7082 (10 µM) before LPS stimulation (10 µg/mL, 4 h). Expression of adhesion molecules (E-selectin, VCAM-1, ICAM-1) and cytokines (IL-6, IL-8) was evaluated using western blotting and ELISA. Leukocyte-endothelial adhesion was measured spectrophotometrically. Molecular docking assessed rubraxanthone interactions with canonical IKKβ and the IκB–NF-κB complex.ResultsRubraxanthone was isolated with 99.2% purity; its IC50 was 12.0 μM. Rubraxanthone significantly and dose-dependently reduced LPS-induced expression of adhesion molecules, IL-6, IL-8, and U937 adhesion. Insilico docking showed favourable binding affinities to IKKβ (–8.9 kcal/mol) and the IκB–NF-κB complex (–7.4 kcal/mol), supporting its inhibitory potential on NF-κB signalling.ConclusionCollectively, rubraxanthone attenuates the endothelial inflammatory response, potentially via canonical NF-κB inhibition, serving as a promising candidate for further investigation in inflammatory vascular disorders, including sepsis.